Funding for this research was provided by:
National Health and Medical Research Council (GNT1151065)
Received: 14 March 2021
Accepted: 19 April 2021
First Online: 12 May 2021
: The trial has been approved by the Austin Health Human Research Ethics Committee (HREC/45941/Austin-2018). Verbal informed consent will be provided by the participant (and recorded by the research assistant) prior to the eligibility screen. All participants will provide their own verbal and written informed consent before participating in the project. Signed consent forms will be stored separately to the data to ensure confidentiality and all consent forms will be accessible only by members of the research team and staff of the RACF. Solicited and spontaneously reported adverse events and other unintended effects of the trial interventions and trial conduct will be recorded regularly in line with ethics requirements. Trial conduct will be monitored by the project management team monthly and the trial will be subject to random audit processes conducted by the National Ageing Research Institute. Protocol amendments are reviewed by the Austin Health Human Research Ethics Committee. Major protocol modifications are reported to the sponsor. It is not anticipated that any post-trial care will be required but provision is made in the signed consent form for participants to be aware that they can seek further treatment from their preferred health professional.
: Not applicable.
: The authors declare that they have no competing interests.